anim
research
perform
accord
regul
protocol
approv
institut
anim
care
use
committe
cincinnati
children
hospit
medic
center
protocol
number
adher
nation
institut
health
olaw
regul
anim
assur
number
anim
welfar
act
certif
number
mous
cholangiocyt
cell
line
gener
provid
jame
boyer
yale
liver
care
center
hartford
ct
cell
biowhittak
walkersvil
md
human
cholangiocyt
cell
kindli
provid
dougla
jefferson
new
england
medic
center
tuft
univers
boston
cultur
describ
use
sever
rotaviru
strain
rrv
simian
strain
kindli
provid
h
greenberg
stanford
univers
palo
alto
ca
tuch
name
locat
strain
isol
tulan
nation
primat
research
center
cincinnati
children
hospit
simian
human
strain
gener
provid
yasutaka
hoshino
niaid
grv
goat
strain
gracious
provid
osamu
nakagomi
nagasaki
univers
japan
viru
stock
grown
cell
describ
previous
kept
frozen
thaw
gene
sequenc
gene
segment
strain
obtain
genbank
rrv
tuch
grv
map
put
function
site
may
play
role
rrv
interact
cholangiocyt
number
structur
bioinformat
tool
employ
analyz
extrapol
avail
structur
data
entri
apparatu
includ
sever
solv
conform
spike
protein
pdb
entri
addit
interact
site
predict
use
sppider
http
sppidercchmcorg
combin
solvent
access
predict
data
unbound
well
known
bound
structur
identifi
site
like
get
buri
upon
complex
predict
analyz
context
exist
structur
sequenc
data
use
http
polyviewcchmcorg
consurf
http
consurftauacil
evolutionari
trace
annot
server
http
mammothbcmtmceduetaindexhtml
synthet
peptid
span
differ
region
protein
rrv
tuch
strain
synthes
purifi
way
liquid
chromatographi
kept
lyophil
genscript
piscataway
nj
unrel
peptid
ghrp
size
random
sequenc
peptid
ident
amino
acid
aa
composit
synthes
use
control
peptid
resuspend
dulbecco
modifi
eagl
medium
use
replic
assay
biotinyl
trtrvsrli
peptid
synthes
use
fmoc
strategi
two
biotin
moieti
attach
motif
separ
hexano
acid
genscript
abil
viru
attach
cholangiocyt
assess
bind
assay
describ
briefli
cell
grown
confluenc
plate
cell
medium
inocul
viru
cool
cell
inocul
vari
amount
viru
incub
hour
inoculum
remov
cell
wash
twice
remov
unbound
viru
cell
underw
two
freezethaw
cycl
viru
within
final
cell
fraction
repres
attach
viru
wash
residu
inoculum
combin
combin
solut
repres
unbound
viru
amount
bound
unbound
viru
determin
way
focu
form
assay
amount
attach
viru
express
percent
total
amount
viru
use
inocul
cell
focu
form
assay
use
determin
presenc
infecti
rotaviru
describ
briefli
plate
treat
serial
dilut
viru
incub
hour
aceton
fixat
guinea
pig
immunoglobulin
g
primari
antibodi
ad
incub
minut
well
aspir
wash
salin
fluorescein
goat
pig
immunoglobulin
g
secondari
antibodi
ad
minut
well
wash
twice
plate
score
use
ultraviolet
microscopi
object
quantiti
infecti
viru
report
ffu
per
milligram
tissu
anim
studi
perform
accord
institut
anim
welfar
guidelin
use
approv
anim
protocol
experiment
model
biliari
atresia
induc
balbc
mice
envigo
lab
indianapoli
newborn
pup
inject
intraperiton
trtrvsrli
ssasaw
peptid
dilut
salin
along
rrv
ffupup
subsequ
inject
peptid
given
day
life
pup
monitor
day
clinic
sign
hepatobiliari
injuri
ie
achol
stool
bilirubinuria
jaundic
skin
surviv
subset
mice
sacrif
day
infect
extrahepat
biliari
tract
harvest
tissu
analyz
presenc
viru
focu
form
assay
biotinyl
trtrvsrli
peptid
synthes
genscript
peptid
design
biotin
linker
affin
mg
immobil
peptid
ad
confluent
monolay
cholangiocyt
incub
hour
incub
cell
lyse
membran
fraction
isol
use
nacl
buffer
membran
fraction
later
treat
streptavidin
agaros
peirc
rockford
il
pull
bound
control
sampl
lysi
buffer
use
includ
sampl
peptid
ad
extens
wash
bound
protein
elut
immobil
peptid
boil
sd
sampl
buffer
run
polyacrylamid
gel
band
excis
gel
describ
eismann
et
mass
list
gener
mass
spectrometri
appli
biosystem
forest
citi
ca
ident
search
perform
use
mascot
search
algorithm
matrix
scienc
boston
scan
current
version
nation
center
biotechnolog
inform
sequenc
databas
signific
ident
judg
search
engin
score
system
transfect
small
interf
rna
sirna
reduc
express
perform
describ
sirna
sequenc
follow
sequenc
gcuugaguaaggaagauau
sequenc
gauuaagucaguccaagaa
sequenc
ucacggacacagagagauu
sequenc
ccacagggacccaaaacaa
dharmacon
lafayett
co
nontarget
sirna
purchas
dharmacon
immunohistochemistri
western
blot
analysi
use
detect
reduc
membran
express
immunocytochemistri
perform
harvest
cholangiocyt
sirna
transfect
cytospin
centrifug
cell
onto
slide
slide
fix
paraformaldehyd
block
normal
donkey
serum
slide
incub
overnight
rat
antibodi
dilut
dako
antibodi
diluent
incub
slide
wash
salin
incub
alexafluor
secondari
antibodi
follow
incub
hour
room
temperatur
slide
wash
embed
dapi
mount
media
visual
fluoresc
microscop
nikon
eclips
analysi
noncontinu
variabl
perform
use
fisher
exact
test
result
continu
variabl
express
mean
standard
error
analyz
use
analysi
varianc
post
hoc
test
appropri
p
consid
statist
signific
statist
analysi
perform
use
prism
graphpad
softwar
la
jolla
ca
use
sppider
program
identifi
possibl
interact
site
predict
number
put
protein
interact
site
http
nine
possibl
site
interest
six
determin
aa
sequenc
analog
strain
caus
murin
ba
tuch
exclud
analysi
synthet
peptid
gener
three
remain
peptid
sequenc
ptaagv
ssasaw
trtrvsrli
use
subsequ
studi
fig
vitro
peptid
bind
assay
synthet
peptid
interest
deriv
protein
ptaagv
ssasaw
trtrvsrli
use
determin
specif
sequenc
involv
cholangiocyt
bind
investig
cholangiocyt
bind
determin
trtrvsrli
peptid
abl
block
rrv
bind
manner
increas
concentr
peptid
mm
mm
mm
result
block
viru
percent
control
media
without
peptid
significantli
decreas
compar
treatment
media
alon
respect
p
convers
ptaagv
ssasaw
peptid
interfer
bind
dgea
domain
cholangiocyt
receptor
shown
involv
rrv
therefor
use
posit
control
result
decreas
viral
bind
ghrp
nonspecif
peptid
use
neg
control
shown
abil
inhibit
rrv
fig
determin
whether
cholangiocyt
surfac
block
synthet
peptid
effect
viral
replic
block
assay
perform
follow
incub
hour
viral
yield
cholangiocyt
treat
increas
dosag
synthet
trtrvsrli
peptid
significantli
lower
media
ghrp
peptid
control
p
wherea
ptaagv
ssasaw
peptid
effect
viral
yield
fig
trtrvsrli
peptid
demonstr
similar
block
cell
http
shown
induct
ba
murin
model
rotaviru
investig
rrv
grv
goat
strain
abl
induc
murin
model
tuch
simian
strain
human
strain
could
block
replic
assay
perform
cholangiocyt
use
synthet
trtrvsrli
peptid
rotaviru
strain
trtrvsrli
peptid
inhibit
bind
rrv
grv
strain
respect
compar
control
p
convers
peptid
effect
viral
bind
tuch
strain
fig
similarli
viral
yield
reduc
rrv
grv
control
p
respect
wherea
cholangiocyt
infect
tuch
show
reduct
viral
yield
treatment
trtrvsrli
peptid
fig
trtrvsrli
constitut
aa
sequenc
rrv
aa
sequenc
strain
includ
tuch
differ
rrv
fig
inform
use
synthes
peptid
region
found
respect
virus
determin
whether
inhibit
bind
replic
cholangiocyt
treat
mrtrvsgli
vrtrisgli
tuch
peptid
bind
replic
assay
perform
describ
previous
trtrvsrli
peptid
abl
inhibit
bind
replic
rrv
effect
tuch
mrtrvsgli
vrtrisgli
effect
strain
assess
fig
c
suggest
strain
rrv
grv
use
trtrvsrli
sequenc
cholangiocyt
bind
site
determin
trtrvsrli
peptid
play
role
rrv
bind
cholangiocyt
infect
next
object
identifi
specif
aa
within
aa
peptid
respons
function
rrv
peptid
differ
two
aa
synthes
peptid
singl
aa
chang
mrtrvsrli
trtrvsgli
evalu
region
peptid
critic
bind
replic
alter
aa
impact
inhibit
bind
replic
trtrvsrli
mrtrvsrli
significantli
inhibit
rrv
function
howev
alter
peptid
inhibit
peptid
abil
block
bind
replic
fig
b
result
suggest
critic
portion
aa
sequenc
lay
within
last
five
residu
investig
latter
half
trtrvsrli
sequenc
determin
aa
govern
peptid
function
peptid
measur
aa
synthes
singl
aa
chang
posit
vsrli
sequenc
assay
rotaviru
bind
replic
reveal
peptid
srl
aa
sequenc
preserv
vsrli
isrli
vsrla
maintain
abil
inhibit
viru
bind
replic
peptid
r
l
peptid
modifi
vvrli
vsgli
vsray
unabl
exhibit
inhibit
fig
result
suggest
presenc
srl
aa
sequenc
integr
bind
viral
replic
prove
trtrvsrli
peptid
play
similar
role
vivo
pup
inocul
peptid
rrv
birth
follow
peptid
day
life
symptom
achol
stool
bilirubinuria
jaundic
weight
loss
record
day
mice
inject
trtrvsrli
peptid
along
rrv
develop
significantli
less
symptom
compar
inject
rrv
ssasaw
peptid
salin
versu
versu
respect
p
fig
surviv
similarli
improv
pup
given
trtrvsrli
peptid
mortal
compar
ssasaw
peptid
salin
fig
bile
duct
harvest
day
infect
ssasaw
trtrvsrli
mice
stain
hematoxylin
eosin
mice
treat
ssasaw
peptid
exhibit
complet
obstruct
bile
duct
wherea
treat
trtrvsrli
mild
inflamm
patent
lumen
fig
viral
titer
obtain
extrahepat
bile
duct
day
inject
rrv
expect
bile
duct
mice
treat
trtrvsrli
peptid
significantli
lower
amount
viru
treat
ssasaw
peptid
control
fig
thu
prove
synthet
peptid
trtrvsrli
competit
inhibit
viral
replic
subsequ
attenu
diseas
phenotyp
test
relev
trtrvsrli
peptid
human
rotaviru
infect
next
perform
bind
replic
assay
human
cholangiocyt
cell
similar
experi
perform
mous
cholangiocyt
treatment
mm
trtrvsrli
peptid
significantli
reduc
abil
rrv
bind
replic
within
human
cholangiocyt
control
respect
fig
b
previous
report
infect
human
cholangiocyt
mirror
mous
prove
trtrvsrli
peptid
block
consist
human
cholangiocyt
perform
bind
replic
assay
cell
infect
rrv
tuch
grv
agreement
mous
data
trtrvsrli
peptid
abl
block
bind
rrv
grv
cell
effect
tuch
bind
fig
ident
effect
observ
replic
rrv
grv
exhibit
reduc
viral
yield
treatment
trtrvsrli
peptid
fig
identifi
srl
peptid
correspond
cholangiocyt
receptor
cell
membran
fraction
treat
synthet
biotinyl
trtrvsrli
peptid
describ
previous
isol
bound
protein
polyacrylamid
gel
analysi
identifi
protein
interest
kda
protein
fig
interestingli
implic
rotaviru
cell
entri
secondari
interact
involv
determin
whether
cholangiocyt
receptor
srl
sequenc
rrv
sirna
use
knock
express
sirna
combin
four
sequenc
target
gene
transfect
cholangiocyt
follow
immunostain
sirna
refer
cell
treat
transfect
agent
without
sirna
use
neg
control
combin
scrambl
neg
incap
block
cellular
function
use
second
neg
control
hour
transfect
sirna
decreas
cholangiocyt
surfac
express
detect
fig
bind
assay
perform
cholangiocyt
infect
rrv
valid
role
viral
bind
treat
sirna
display
signific
decreas
rrv
bind
replic
compar
cholangiocyt
treat
neg
control
fig
cholangiocyt
underw
trtrvsrli
peptid
bind
assay
reveal
express
cholangiocyt
led
inabl
trtrvsrli
block
rrv
bind
treat
neg
control
sirna
remain
suscept
inhibit
rrv
attach
cell
remain
sensit
dgea
block
regardless
treatment
fig
percent
control
normal
cell
treat
serum
free
media
absenc
peptid
present
rrv
replic
similarli
assess
use
neg
sirna
sirna
neg
sirna
remain
suscept
dgea
synthet
trtrvsrli
peptid
viral
blockad
viral
replic
cell
result
chang
viral
yield
trtrvsrli
peptid
normal
control
absenc
viral
bind
yield
lower
treatment
group
fig
previou
studi
shown
secondari
interact
exist
rotaviru
strain
studi
secondari
interact
mediat
aa
sequenc
within
span
aa
term
fsg
fsgikstidaaksmatnvmkkfkk
term
kid
ktkidrstqispntlpd
experi
cell
treat
peptid
display
reduc
viral
replic
due
decreas
viral
use
fsg
kid
peptid
determin
whether
involv
primari
bind
replic
cholangiocyt
similarli
srl
peptid
block
assay
use
three
differ
peptid
demonstr
trtrvsrli
capabl
significantli
inhibit
primari
viral
bind
wherea
fsg
kid
effect
fig
addit
three
peptid
inhibit
rrv
replic
result
confirm
trtrsvrli
block
rrv
primari
attach
cholangiocyt
result
reduc
replic
rate
wherea
fsg
kid
peptid
effect
primari
bind
reduc
interact
reflect
reduc
viral
yield
fig
ba
devast
diseas
affect
newborn
first
month
life
character
bile
duct
obstruct
liver
injuri
progress
fibrosi
without
treatment
death
although
etiolog
ba
remain
unclear
perinat
viral
infect
implic
sever
virus
includ
rotaviru
may
play
role
activ
inflammatori
autoimmun
murin
model
ba
rrv
contribut
releas
cytokin
immun
cell
although
exact
mechan
rotaviru
play
role
yet
elucid
current
studi
indic
viru
target
biliari
epithelium
lead
inflamm
extrahepat
biliari
shown
previous
gene
rrv
play
integr
role
murin
ba
model
induct
cholangiocyt
immun
cell
coulson
et
discov
collagen
sequenc
dge
rotaviru
determin
bind
integrin
cholangiocyt
receptor
use
primari
rotaviru
bind
found
hepatocyt
cho
cell
less
suscept
line
suggest
receptor
may
govern
rrv
use
sequenc
structur
base
model
approach
determin
three
peptid
sequenc
within
rrv
protein
map
put
bind
site
select
treatment
peptid
ptaagv
trtrvsrli
ssasaw
determin
trtrvsrli
aa
abl
decreas
rrv
bind
subsequ
replic
murin
cholangiocyt
along
cell
cell
type
rotaviru
replic
effici
peptid
capabl
inhibit
rrv
grv
two
strain
homolog
trtrvsrli
sequenc
induc
murin
ba
howev
capabl
inhibit
bind
tuch
virus
dissimilar
peptid
sequenc
induc
murin
ba
result
suggest
trtrvsrli
essenti
peptid
play
role
cellular
bind
within
trtrvsrli
sequenc
determin
sequenc
srl
play
critic
role
establish
peptid
govern
bind
entri
specif
rotaviru
strain
capabl
induc
murin
determin
role
rrv
trtrvsrli
peptid
human
ba
perform
similar
experi
human
cholangiocyt
cell
cell
analysi
determin
trtrvsrli
peptid
also
capabl
diminish
rrv
grv
bind
viral
replic
strain
capabl
induc
murin
model
ba
import
note
human
rotaviru
strain
isol
contain
trtrvsrli
sequenc
unfortun
strain
maintain
result
avail
studi
establish
import
trtrvsrli
peptid
vitro
infect
cholangiocyt
evalu
function
vivo
model
ba
investig
determin
trtrvsrli
peptid
play
role
murin
model
ba
lessen
symptom
mortal
well
result
lower
viral
titer
bile
duct
mice
follow
determin
srl
specif
sought
correspond
cholangiocyt
membran
receptor
peptid
found
cholangiocyt
srl
attach
occur
protein
constitut
express
chaperon
within
famili
protein
involv
variou
cellular
function
includ
uncoat
protein
protein
degrad
import
protein
protein
also
inflamm
infect
malign
interact
cell
low
densiti
lipoprotein
protein
may
result
transloc
nuclear
factor
nucleu
dendrit
cell
rotaviru
cell
entri
shown
complex
multistep
process
variou
cellular
receptor
includ
integrin
present
cell
surfac
multipl
nonsuscept
cell
type
includ
monkey
human
cell
believ
essenti
infect
suscept
cell
block
antibodi
abil
rotaviru
infect
cell
protein
shown
involv
secondari
rotaviru
bind
way
peptid
sequenc
kid
fsg
rotaviru
capsid
protein
compos
later
cleav
respons
initi
cell
interact
shown
play
essenti
role
cellular
bind
previou
investig
aa
sequenc
within
protein
zarat
et
provid
knowledg
specif
bind
occur
kid
aa
domain
block
domain
imped
viral
replic
though
bind
suggest
secondari
bind
site
similarli
gualtero
et
show
fsg
peptid
aa
within
implic
bind
also
play
role
rotaviru
replic
though
primari
bind
investig
trtrvsrli
peptid
determin
uniqu
peptid
unlik
previous
describ
peptid
interact
primari
bind
phase
domain
rrv
wherea
previous
establish
peptid
involv
step
thu
block
sirna
signific
effect
block
rrv
bind
replic
rrv
howev
similar
previou
report
inhibit
trtrsvrli
also
kid
fsg
studi
underway
elucid
differ
interestingli
analysi
nation
center
biotechnolog
inform
blastp
databas
http
blastncbinlmnihgovblastcgi
pageprotein
programblastp
blastprogramsblastp
pagetypeblastsearch
dbsearchtru
queri
subject
presenc
vsrli
peptid
also
found
virus
includ
reoviru
cytomegaloviru
human
papillomaviru
viru
bluetongu
viru
polyomaviru
coronaviru
respiratori
syncyti
viru
adenoviru
rodent
paramyxoviru
cyprinid
canin
picodicistroviru
herp
simplex
viru
toroviru
chicken
galliviru
sever
cytomegaloviru
viru
human
papillomaviru
reoviru
found
explant
liver
infant
aa
sequenc
found
viral
attach
protein
cytomegaloviru
reoviru
viru
human
papillomaviru
also
locat
viral
capsid
thu
sequenc
may
involv
cholangiocyt
bind
similar
fashion
rrv
vsrli
peptid
role
bind
human
ba
induct
function
protein
yet
establish
conclus
find
support
concept
rotaviru
bind
entri
process
multifacet
involv
bind
sever
peptid
primari
secondari
fashion
integrin
investig
underway
identifi
cellular
respons
follow
interact
peptideviru
understand
pathogenesi
ba
